Cargando…

Cardiovascular Safety and Benefits of Testosterone Implant Therapy in Postmenopausal Women: Where Are We?

We discuss the CV safety and efficacy data for subcutaneous testosterone therapy (STT) in postmenopausal women. We also highlight new directions and applications of correct dosages performed in a specialized center. To recommend STT, we propose innovative criteria (IDEALSTT) according to total testo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Renke, Guilherme, Tostes, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146246/ https://www.ncbi.nlm.nih.gov/pubmed/37111376 http://dx.doi.org/10.3390/ph16040619

Ejemplares similares

50 Years of Women in Cell Biology: Where have we been? Where are we going?
por: Masur, Sandra K., et al.
Publicado: (2021)

Mathematics anxiety—where are we and where shall we go?
por: Cipora, Krzysztof, et al.
Publicado: (2022)

Bcr-Abl Allosteric Inhibitors: Where We Are and Where We Are Going to
por: Carofiglio, Francesca, et al.
Publicado: (2020)

Women in neuroscience: Where are we in 2019?
por: Machlovi, Saima, et al.
Publicado: (2020)

Natural Products and Synthetic Biology: Where We Are and Where We Need To Go
por: Kunakom, Sylvia, et al.
Publicado: (2019)

Point-of-care screening for atrial fibrillation: Where are we, and where do we go next?
por: Ashburner, Jeffrey M., et al.
Publicado: (2021)

Drug Design: Where We Are and Future Prospects
por: Zagotto, Giuseppe, et al.
Publicado: (2021)

Welcoming low testosterone as a cardiovascular risk factor
por: Maggio, M, et al.
Publicado: (2009)

Primary osteoporosis in postmenopausal women
por: Ji, Meng-Xia, et al.
Publicado: (2015)

Automated clinical coding: what, why, and where we are?
por: Dong, Hang, et al.
Publicado: (2022)

Testosterone replacement therapy in the era of telemedicine
por: Dubin, Justin M., et al.
Publicado: (2021)

Breast cancer causes and treatment: where are we going wrong?
por: Seymour, Colin B, et al.
Publicado: (2013)

COVID toes: where do we stand with the current evidence?
por: Baeck, Marie, et al.
Publicado: (2021)

Cancer prevention through weight control—where are we in 2020?
por: Anderson, Annie S., et al.
Publicado: (2020)

Epigenetics studies of fetal alcohol spectrum disorder: where are we now?
por: Lussier, Alexandre A, et al.
Publicado: (2017)

FDG-PET/CT in Lymphoma: Where Do We Go Now?
por: Al Tabaa, Yassine, et al.
Publicado: (2021)

Toward a genome sequence for every animal: Where are we now?
por: Hotaling, Scott, et al.
Publicado: (2021)

Preventing Retinal Detachment: Where are We? Implications from Stickler Syndrome
por: Morris, Robert E, et al.
Publicado: (2022)

MR-Guided Focused Ultrasound for Refractory Epilepsy: Where Are We Now?
por: Labate, Angelo, et al.
Publicado: (2023)

The evolution of bacterial genome assemblies - where do we need to go next?
por: Altermann, Eric, et al.
Publicado: (2022)

Editorial: The Future of Environmental Medicine in Environmental Health Perspectives: Where Should We Be Headed?
por: Schwartz, Brian S., et al.
Publicado: (2005)

Location, Location, Location: Where We Teach Primary Care Makes All the Difference
por: Cassel, Christine, et al.
Publicado: (2017)

Cancer survivorship, excess body fatness and weight-loss intervention—where are we in 2020?
por: Anderson, Annie S., et al.
Publicado: (2020)

Heritage Conservation Future: Where We Stand, Challenges Ahead, and a Paradigm Shift
por: Otero, Jorge
Publicado: (2021)

MHC Restriction: Where Are We Now?
por: Zareie, Pirooz, et al.
Publicado: (2020)

Low Free Testosterone Levels Are Associated With All-Cause and Cardiovascular Mortality in Postmenopausal Diabetic Women
por: Wehr, Elisabeth, et al.
Publicado: (2011)

Where are we heading in post-China angioplasty and stenting for symptomatic intracranial severe stenosis era?
por: Xue, Fang, et al.
Publicado: (2023)

Deep Brain Stimulation for Addictive Disorders—Where Are We Now?
por: Yuen, Jason, et al.
Publicado: (2022)

Associations of Estrogen and Testosterone With Insulin Resistance in Pre- and Postmenopausal Women With and Without Hormone Therapy
por: Matsui, Sumika, et al.
Publicado: (2013)

Cardiovascular Tissue Engineering: Where We Come From and Where Are We Now?
por: Smit, Francis E., et al.
Publicado: (2015)

Bioavailable testosterone is independently associated with Fatty Liver Index in postmenopausal women
por: Klisic, Aleksandra, et al.
Publicado: (2017)

Breast Implant Surfaces and Their Impact on Current Practices: Where We Are Now and Where Are We Going?
por: Munhoz, Alexandre Mendonça, et al.
Publicado: (2019)

Cardiovascular Benefits of Exercise Training in Postmenopausal Hypertension
por: Lin, Yi-Yuan, et al.
Publicado: (2018)

Potential benefits of Chinese Herbal Medicine for elderly patients with cardiovascular diseases
por: Luo, Jing, et al.
Publicado: (2013)

Developmental Programming of Obesity and Diabetes in Mouse, Monkey, and Man in 2018: Where Are We Headed?
por: Friedman, Jacob E.
Publicado: (2018)

Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
por: Hwang, Kathleen, et al.
Publicado: (2015)

Systematic Reviews in Occupational Health and Safety: where are we and where should we go?
por: Verbeek, Jos, et al.
Publicado: (2019)

Implantable Hearing Aids: Where are we in 2020?
por: Banakis Hartl, Renee M., et al.
Publicado: (2020)

Portomesenteric venous thrombosis in a postmenopausal female with testosterone implant: a case report
por: Campitruz, Monica Zanconato, et al.
Publicado: (2021)

Molecular Targets for Endometriosis Therapy: Where We Are and Where We Are Going?
por: Barra, Fabio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_72q9uh6h6rho5d9b2qkt8m2bs5